Nature Communications (Feb 2021)

Discrete SARS-CoV-2 antibody titers track with functional humoral stability

  • Yannic C. Bartsch,
  • Stephanie Fischinger,
  • Sameed M. Siddiqui,
  • Zhilin Chen,
  • Jingyou Yu,
  • Makda Gebre,
  • Caroline Atyeo,
  • Matthew J. Gorman,
  • Alex Lee Zhu,
  • Jaewon Kang,
  • John S. Burke,
  • Matthew Slein,
  • Matthew J. Gluck,
  • Samuel Beger,
  • Yiyuan Hu,
  • Justin Rhee,
  • Eric Petersen,
  • Benjamin Mormann,
  • Michael de St Aubin,
  • Mohammad A. Hasdianda,
  • Guruprasad Jambaulikar,
  • Edward W. Boyer,
  • Pardis C. Sabeti,
  • Dan H. Barouch,
  • Boris D. Julg,
  • Elon R. Musk,
  • Anil S. Menon,
  • Douglas A. Lauffenburger,
  • Eric J. Nilles,
  • Galit Alter

DOI
https://doi.org/10.1038/s41467-021-21336-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

The extent of antibody protection against SARS-CoV-2 remains unclear. Here, using a cohort of 120 seroconverted individuals, the authors longitudinally characterize neutralization, Fc-function, and SARS-CoV-2 specific T cell responses, which they show to be prominent only in those subjects that elicited receptor-binding domain (RBD)-specific antibody titers above a certain threshold, suggesting that development of T cell responses to be related to anti-RBD Ab production.